Pleased to have @washingtonpost run my letter to the editor today. It’s critically important that #biopharma speak up to ensure that the drug pricing discourse isn’t dominated by misinformation. https://www.washingtonpost.com/opinions/federal-research-is-important-but-companies-turn-it-into-actual-treatments/2019/04/11/bb3bd2b4-5bae-11e9-98d4-844088d135f2_story.html?utm_term=.9ab3c47acfd5 …